Radiation dose to the masseter and medial pterygoid muscle in relation to trismus after chemoradiotherapy for advanced head and neck cancer.
Sophie A KraaijengaOlga Hamming-VriezeSonja VerheijenEmmy LamersLisette van der MolenFrans J HilgersMichiel W van den BrekelWilma D HeemsbergenPublished in: Head & neck (2019)
Both iMPM and iMM doses, as well as bMIO, are clinically relevant parameters for trismus prediction.